RemeGen Co., Ltd. (HKG:9995)
Hong Kong
· Delayed Price · Currency is HKD 46.00
-1.30 (-2.75%)
Jun 6, 2025, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 32.87 billion as of June 6, 2025. Its market cap has increased by 25.27% in one year.
Market Cap
32.87B
Enterprise Value
35.03B
Revenue
2.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
46.00
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has decreased from 33.39B to 32.87B, a decrease of -1.54%. That is a compound annual growth rate of -0.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 32.87B | 134.74% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 239.16B |
| Hansoh Pharmaceutical Group Company | 161.73B |
| JD Health International | 126.72B |
| Innovent Biologics | 120.66B |
| CSPC Pharmaceutical Group | 101.26B |
| WuXi Biologics | 100.29B |
| Sino Biopharmaceutical | 81.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 75.34B |